Abstract
화장품용 방부제인 CPN-Gal은 사람 피부세포에 대하여 보다 안전하다고 알려져있다. 장기간에 걸쳐서 CPN-Gal을 생산하는 공정을 확립하기 위하여, β-gal을 생산하는 재조합 대장균을 alginate bead에 고정화 시켜서, 반복 회분식 반응으로 CPN으로부터 CPN-Gal로의 전환반응(transgalactosylation)을 조사하여 보았다. 이 전환반응은 300 ml flask에서 수행하였으며, 반응액에는 고정화된 대장균, 33.8 mM CPN, 400 g/l lactose가 포함되어있으며, pH와 온도는 7.0과 40℃ 였다. 이 때, galactose 한 분자가 lactose로부터 CPN으로 전달된다. 반복 회분식 전환반응은 4회 연속적으로 192시간 동안 성공적으로 수행이 가능하였고, 이 때, 64%의 전환수율을 보였으며, 이 결과는 선행연구 결과에 비하여 보다 우수한 결과이다. 그런데, 반복 회분식 반응이 진행되면서, 192시간 이후부터는 점진적으로 전환수율의 감소가 관찰되었다. western blotting으로 β-gal의 양을 관찰하여본 결과, β-gal의 양의 감소가 관찰되었으며, alginate beads에서 깨어진 금이 또한 발견되었다. 이러한 bead의 깨어짐 현상과 아울러서 β-gal의 불활성화, 그리고 galactose에 의한 product inhibition 등이 192시간 이후의 전환수율 감소의 원인으로 생각된다. 본 연구의 전환공정은 β-gal의 정제가 필요 없이 진행할 수 있기 때문에, CPN-Gal 합성이 보다 실용적이고, 가격 경쟁력 있게 수행될 수 있을 것으로 생각된다. 그래서, 이러한 전환공정이 CPN-Gal을 상업화하기 위한 공정으로 발전하길 기대하고 있다. Previous research showed that chlorphenesin galactoside (CPN-Gal), a preservative in cosmetics, was safer than CPN against human skin cells <xref>[9]</xref>. To establish a stable and long-term process for CPN-Gal production, we investigated the repeated-batch process. In this process, β-gal-producing recombinant Escherichia coli cells were immobilized in calcium alginate beads, and CPN was converted to CPN-Gal by the transgalactosylation reaction. The process was conducted in a 300 ml flask, which contained E. coli cell-immobilized alginate beads, 33.8 mM of CPN, and 400 g/l of lactose. The pH and temperature were 7.0 and 40℃, respectively. During the repeated-batch operation, four consecutive batch operations were conducted successfully until 192 hr. The conversion yield of CPN to CPN-Gal was 64% during 192 hr, which was higher than the values in previous reports <xref>[3</xref>, <xref>13]</xref>. Thereafter, however, the conversion yield gradually decreased until the operation was finished at 336 hr. Western blotting of immobilized E. coli cells revealed that β-gal gradually decreased after 192 hr. In addition, alginate beads were cracked when the operation was finished. It is probable that, including this loss of E. coli cells by cracks, deactivation, and product inhibition of E. coli β-gal might lead to a gradual decrease in the production of CPN-Gal after 192 hr. However, as the purification of β-gal is not necessary with β-gal-producing recombinant E. coli cells, β-gal-producing E. coli cells might be a practical and cost-effective approach for enzymatically synthesizing CPN-Gal. It is expected that this process will be extended to long-term production process of CPN-Gal for commercialization.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
